Table 2 Patients’ demographic and clinical characteristics
First Author | Publication Year | Sample Data T/I/C(n) | Age (Mean ± SD) | Male (n, %) | T2DM Duration (Years) | Cardiovascular Death I/C (n) | Primary Composite Outcome I/C (n) | Myocardial Infarction I/C (n) | Stroke I/C (n) | All-Cause Death I/C (n) | HF Hospitalization I/C (n) | UA Hospitalization I/C (n) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hernandez | 2018 | 9,463/ 4,731/ 4,732 | 64.1 ± 8.7 | 3304, 70.0% | 14.1 | 122/ 130 | 338/ 428 | 181/ 240 | 94/ 108 | 196/ 205 | 188/ 218 | / |
Gerstein | 2019 | 9,901/ 4,949/ 4,952 | 66.2 ± 6.5 | 5312, 53.7% | 10.6 | 317/ 346 | 594/ 663 | 223/ 231 | 158/ 205 | 536/ 592 | 213/ 226 | 88/ 77 |
Pfeffer | 2015 | 6,068/ 3,034/ 3,034 | 60.1 ± 9.6 | 4207, 69.3% | 9.3 | 158/ 156 | 399/ 406 | 261/ 270 | 60/ 67 | 223/ 211 | 127/ 122 | 10/ 11 |
Marso a | 2016 | 9,340/ 4,668/ 4,672 | 64.3 ± 7.2 | 6003, 64.3% | 12.9 | 219/ 278 | 608/ 694 | 292/ 339 | 173/ 199 | 381/ 447 | 218/ 248 | 122/ 124 |
Marso b | 2016 | 3,297/ 1,648/ 1,649 | 64.7 ± 7.4 | 2002, 60.7% | 14.2 | 44/ 46 | 108/ 146 | 47/ 64 | 27/ 44 | 62/ 60 | 59/ 54 | 22/ 27 |
Husain | 2019 | 3,183/ 1,591/ 1,592 | 66.0 ± 7.0 | 2176, 68.4% | 15.0 | 15/ 30 | 61/ 76 | 37/ 31 | 12/ 16 | 23/ 45 | 21/ 24 | 11/ 7 |
Holman | 2017 | 14,752/ 7,356/ 7,396 | 62.0 ± 8.9 | 5603, 38.0% | 12.0 | 340/ 383 | 839/ 905 | 483/ 493 | 187/ 218 | 507/ 548 | 219/ 231 | 602/ 570 |
Gerstein | 2021 | 4,076/ 2,717/ 1,359 | 64.5 ± 8.2 | 2732, 67.0% | 15.4 | 75/ 50 | 189/ 125 | 91/ 58 | 47/ 31 | 111/ 69 | 40/ 31 | 6/ 4 |
Perkovic | 2024 | 3,533/ 1,767/ 1,766 | 66.6 ± 9.0 | 2464, 69.7% | 15.0 | 123/ 169 | / | 52/ 64 | 63/ 51 | 227/ 279 | 133/ 175 | / |